|
Originally published In Press as doi:10.1074/jbc.M000313200 on June 7, 2000
J. Biol. Chem., Vol. 275, Issue 43, 33688-33696, October 27, 2000
High Molecular Weight Kininogen Utilizes Heparan Sulfate
Proteoglycans for Accumulation on Endothelial Cells*
Thomas
Renné,
Jürgen
Dedio,
Guido
David §, and
Werner
Müller-Esterl¶
From the Institute for Biochemistry II, Johann Wolfgang
Goethe-University of Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt,
Germany and the Center for Human Genetics, University of
Leuven and Flanders Interuniversity Institute for Biotechnology, B-3000
Leuven, Belgium
Kininogens, the high molecular weight precursor
of vasoactive kinins, bind to a wide variety of cells in a specific,
reversible, and saturable manner. The cell docking sites have been
mapped to domains D3 and D5H of kininogens; however,
the corresponding cellular acceptor sites are not fully established. To
characterize the major cell binding sites for kininogens exposed by the
endothelial cell line EA.hy926, we digested intact cells with trypsin
and other proteases and found a time- and
concentration-dependent loss of 125I-labeled
high molecular weight kininogen (H-kininogen) binding capacity (up to
82%), indicating that proteins are crucially involved in kininogen
cell attachment. Cell surface digestion with heparinases similarly
reduced kininogen binding capacity (up to 78%), and the combined
action of heparinases and trypsin almost eliminated kininogen binding
(up to 85%), suggesting that proteoglycans of the heparan sulfate type
are intimately involved. Consistently, inhibitors such as
p-nitrophenyl- -D-xylopyranoside and chlorate interfering with heparan sulfate proteoglycan biosynthesis reduced the
total number of kininogen binding sites in a time- and
concentration-dependent manner (up to 67%). In
vitro binding studies demonstrated that biotinylated H-kininogen
binds to heparan sulfate glycosaminoglycans via domains D3 and
D5H and that the presence of Zn2+ promotes this
association. Cloning and over-expression of the major endothelial
heparan sulfate-type proteoglycans syndecan-1, syndecan-2, syndecan-4,
and glypican in HEK293t cells significantly increased total heparan
sulfate at the cell surface and thus the number of kininogen binding
sites (up to 3.3-fold). This gain in kininogen binding capacity was
completely abolished by treating transfected cells with heparinases. We
conclude that heparan sulfate proteoglycans on the surface of
endothelial cells provide a platform for the local accumulation of
kininogens on the vascular lining. This accumulation may allow the
circumscribed release of short-lived kinins from their precursor
molecules in close proximity to their sites of action.
*
This work was supported in part by grants from the Deutsche
Forschungsgemeinschaft (Mu598/5-3), and from the Fonds der Chemischen Industrie (to W. M. E.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by the Flanders Interuniversity Institute for
Bio/Technology and the Fonds voor Wetenschappelijk
Onderzoek-Vlaanderen.
¶
To whom correspondence should be addressed. Tel.:
49-69-6301-5652; Fax: 49-69-6301-5577; E-mail: wme@biochem2.de.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. J. Williams
Some Things Just Have to Be Done In Vivo: GPIHBP1, Caloric Delivery, and the Generation of Remnant Lipoproteins
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2009;
29(6):
792 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Renne, K. Schuh, and W. Muller-Esterl
Local Bradykinin Formation Is Controlled by Glycosaminoglycans
J. Immunol.,
September 1, 2005;
175(5):
3377 - 3385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Veenstra, T. P. Conrads, B. L. Hood, A. M. Avellino, R. G. Ellenbogen, and R. S. Morrison
Biomarkers: Mining the Biofluid Proteome
Mol. Cell. Proteomics,
April 1, 2005;
4(4):
409 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kawasaki, T. Maeda, K. Hanasawa, I. Ohkubo, and T. Tani
Effect of His-Gly-Lys Motif Derived from Domain 5 of High Molecular Weight Kininogen on Suppression of Cancer Metastasis Both in Vitro and in Vivo
J. Biol. Chem.,
December 5, 2003;
278(49):
49301 - 49307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Chavakis, S. Santoso, K. J. Clemetson, U. J. H. Sachs, I. Isordia-Salas, R. A. Pixley, P. P. Nawroth, R. W. Colman, and K. T. Preissner
High Molecular Weight Kininogen Regulates Platelet-Leukocyte Interactions by Bridging Mac-1 and Glycoprotein Ib
J. Biol. Chem.,
November 14, 2003;
278(46):
45375 - 45381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Baird and P. N. Walsh
Factor XI, but Not Prekallikrein, Blocks High Molecular Weight Kininogen Binding to Human Umbilical Vein Endothelial Cells
J. Biol. Chem.,
May 30, 2003;
278(23):
20618 - 20623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Houle, G. Molinaro, A. Adam, and F. Marceau
Tissue Kallikrein Actions at the Rabbit Natural or Recombinant Kinin B2 Receptors
Hypertension,
March 1, 2003;
41(3):
611 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Baird and P. N. Walsh
The Interaction of Factor XIa with Activated Platelets but Not Endothelial Cells Promotes the Activation of Factor IX in the Consolidation Phase of Blood Coagulation
J. Biol. Chem.,
October 4, 2002;
277(41):
38462 - 38467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Chavakis, R. A. Pixley, I. Isordia-Salas, R. W. Colman, and K. T. Preissner
A Novel Antithrombotic Role for High Molecular Weight Kininogen as Inhibitor of Plasminogen Activator Inhibitor-1 Function
J. Biol. Chem.,
August 30, 2002;
277(36):
32677 - 32682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Chavakis, N. Boeckel, S. Santoso, R. Voss, I. Isordia-Salas, R. A. Pixley, E. Morgenstern, R. W. Colman, and K. T. Preissner
Inhibition of Platelet Adhesion and Aggregation by a Defined Region (Gly-486-Lys-502) of High Molecular Weight Kininogen
J. Biol. Chem.,
June 21, 2002;
277(26):
23157 - 23164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. C. A. Lima, P. C. Almeida, I. L. S. Tersariol, V. Schmitz, A. H. Schmaier, L. Juliano, I. Y. Hirata, W. Muller-Esterl, J. R. Chagas, and J. Scharfstein
Heparan Sulfate Modulates Kinin Release by Trypanosoma cruzi through the Activity of Cruzipain
J. Biol. Chem.,
February 15, 2002;
277(8):
5875 - 5881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Renne, D. Gailani, J. C. M. Meijers, and W. Muller-Esterl
Characterization of the H-kininogen-binding Site on Factor XI. A COMPARISON OF FACTOR XI AND PLASMA PREKALLIKREIN
J. Biol. Chem.,
February 8, 2002;
277(7):
4892 - 4899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. CHAVAKIS, S. M. KANSE, R. A. PIXLEY, A. E. MAY, I. ISORDIA-SALAS, R. W. COLMAN, and K. T. PREISSNER
Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen
FASEB J,
November 1, 2001;
15(13):
2365 - 2376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mahdi, Z. Shariat-Madar, R. F. Todd III, C. D. Figueroa, and A. H. Schmaier
Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells
Blood,
April 15, 2001;
97(8):
2342 - 2350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Scharfstein, V. Schmitz, V. Morandi, M. M. A. Capella, A. P. C. A. Lima, A. Morrot, L. Juliano, and W. Muller-Esterl
Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B2 receptors
J. Exp. Med.,
November 6, 2000;
192(9):
1289 - 1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Joseph, B. G. Tholanikunnel, and A. P. Kaplan
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII
PNAS,
January 22, 2002;
99(2):
896 - 900.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|